Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (e):
- Establishes the Defense Health Agency’s (DHA) procedures for implementing and managing high quality information technology (IT) services by the Chief Information Officer (CIO), Deputy Assistant Director Information Operations (DAD IO/J-6), Military Health System (MHS). The DHA Service Delivery Management program provides customers requesting IT services from the DAD IO/J-6 or Defense Information Systems Agency service catalogs with an on-demand, automated system that provides a single-entry point to submit service requests. The automated system enables DAD IO/J-6 to align business needs and use repeatable and scalable processes to holistically track, manage, and report on customer submitted requests for IT services from submission to fulfillment.
- Is binding on DoD Components and supports the Director’s, DHA, responsibility to develop appropriate management models to maximize efficiencies in the activities carried out by the DHA.
- This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction (DHA-PI). This DHA-IPM will expire effective 12 months from the date of issue.
- Identification #: 18-007
- Date: 7/28/2020
- Type: DHA Interim Procedures Memorandum
- Topics:
Technology
Policy
This Defense Health Agency-Administrative Instruction (DHA-AI), establishes a Defense Health Agency (DHA) Component Information Collection Program, policy, and procedures necessary to license SOIC, that require responses from DHA personnel and from all organizations that fall under the administration, direction, and control of the DHA. The goal of the program is to minimize redundancy, cost, and burden and improve quality of information being collected by DHA personnel and reported in and outside the organization.
- Identification #: DHA AI 8900.01
- Date: 7/4/2020
- Type: Administrative Instructions
- Topics:
N/A
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), establishes the Defense Health Agency’s (DHA) procedures for translating Defense Health Program (DHP)-funded research into standards of care throughout the Defense Trauma Enterprise (DTE).
- Identification #: DHA PI 6040.05
- Date: 6/26/2020
- Type: DHA Procedural Instruction
- Topics:
N/A
Policy
This Defense Health Agency-Procedural Instruction (DHA-PI), establishes the Defense Health Agency’s (DHA) process to manage Medical Devices and Equipment (MDE) requirements for Military Medical Treatment Facilities (MTFs) and other lines of business across the Military Health System (MHS), enhances readiness, enables trusted patient care, and increases efficiency through world-class health technology delivery.
- Identification #: DHA PI 6000.02
- Date: 6/15/2020
- Type: DHA Procedural Instruction
- Topics:
N/A
Policy
This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.
- Identification #: DHA AI 3020.01
- Date: 6/12/2020
- Type: Administrative Instructions
- Topics:
Coronavirus
Policy
The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.
- Identification #: 20-003
- Date: 5/13/2020
- Type: Memorandums
- Topics:
N/A
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to: Outline responsibilities for MHS and Service Department CM personnel to utilize the CM Screening Registry; Identify requirements to utilize CM coding in alignment with current MHS CM coding guidance; and Require the use of standardized Adult and Pediatric Tri-Service Workflow (TSWF) forms for CM documentation (inclusive of telephonic, virtual, or face to face screening) located within AHLTA system and future Electronic Health Record MHS GENESIS
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (k), establishes Defense Health Agency’s (DHA) procedures that:
• Apply to Active Duty Service members, namely Active Component members and Reserve Component members on active duty for a period of more than 30 days, who, hereafter, are referred to collectively as Active Duty Service members (References (e) and (f)).
• Establish a set of common guidelines, standards, and procedures governing the DoDMEP for military health care personnel in all locations.
• Outline implementing procedures for DHA collaboration with the DoDMEP office, to be known as the DoD Medical Ethics Center (DMEC), which is to operate under the direction of the President of the Uniformed Services University of the Health Sciences (USUHS).
• Implement guidance for the DoD mission, vision, guiding principles of the DoDMEP (DMEC) as set forth in Reference (g) and delineate areas of responsibility between the DHA and USUHS, including:
o The provision of medical ethics education and training (E&T) to health care providers and other health care personnel;
o Creation and maintenance of a DMEC portal; and
o Medical ethics consultation services to MHS health care personnel across all settings.
• This DHA-IPM is effective immediately and will expire effective 12 months from the date of issue.
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (s):
• Establishes the Defense Health Agency’s (DHA) procedures for centralized oversight, standardized operations, and ensured quality and performance for the coding of DoD Health Records.
• This DHA-IPM is effective immediately; it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire 12 months from the date of issue.
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s procedures to authorize the procurement of all ruminant meat (beef, sheep, goat, bison, etc.) and edible products from ruminants of overseas origin. DoD procurement of ruminant meat and meat products will align with current United States Department of Agriculture (USDA) restrictions and residual risk mitigation measures for Bovine Spongiform Encephalopathy (BSE).
- Identification #: 20-003
- Date: 4/10/2020
- Type: DHA Interim Procedures Memorandum
- Topics:
N/A
Policy
This memorandum directs all Military Treatment Facility (MTF) and Dental Treatment Facility (DTF) Commanders and Directors to immediately postpone all elective surgeries, invasive procedures, and dental procedures performed on beneficiaries of the MTFs and DTFs with the exceptions outlined below. This includes aerosol-producing procedures, such as endoscopies, bronchoscopies, pulmonary function tests, and sleep continuous positive airway pressure (CPAP) titrations. This policy is effective March 31, 2020, and will remain in place for 60 days.
- Identification #: N/A
- Date: 3/24/2020
- Type: Memorandums
- Topics:
N/A
Policy
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to implement instructions, assign responsibilities, and prescribe procedures for the Southern Hemisphere Influenza Vaccination Program. All Active Duty, Selected Reserve, and National Guard members receive an annual influenza vaccination. Personnel who are traveling to, conducting a permanent change of station to, or are located in the Southern Hemisphere will receive the Southern Hemisphere influenza vaccine or obtain an exemption (e.g., medical or administrative) in accordance with guidance in paragraph 6.a. of Attachment 2. Military personnel residing in the Southern Hemisphere who have received the Southern Hemisphere influenza vaccine in accordance with Appendix 1, meet the annual influenza immunization requirement.
Policy
Implements the policy in the February 22, 2018 Secretary of Defense Memorandum and the February 2018 DoD Report and Recommendations on Military Service by Transgender Persons, assigns responsibilities, and prescribes procedures regarding the standards for accession, retention, separation, in-service transition, and medical care for Service members and applicants with gender dysphoria, as applicable. This DTM is effective April 12, 2019. This DTM will be incorporated into DoDIs1300.28, 1332.14, 1332.30, and 6130.03, and supersedes any contradictory guidance in those publications. This DTM will expire effective September 12, 2020.
Policy
This DHA-PI establishes Defense Health Agency’s (DHA) procedures to provide key stakeholders’ responsibilities for connecting medical devices to MHS GENESIS; establish clinical expectations for connecting medical devices to MHS GENESIS; provide references for MTFs to use in procuring medical devices that will be connected to MHS GENESIS; and provide process for MTFs to elevate medical device connection issues related to MHS GENESIS.
Policy
This DHA-PI ensures alignment of the Integrated Capabilities Portfolio (ICP) process with the National Military Strategy, support the Quadruple Aim , and ensure every resource is supporting the critical initiatives of the DHA. This effort ensures that every dollar spent provides value back to the Military Health System (MHS), improves efficiency and effectiveness, and supports readiness and health.
- Identification #: DHA PI 5020.01
- Date: 3/11/2020
- Type: DHA Procedural Instruction
- Topics:
N/A
Showing results 31 - 45
Page 3 of 78